- Home
- FULC vs MYO Comparison
FULC vs MYO Comparison
Compare FULC & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- MYO
- Stock Information
- Founded
- FULC 2015
- MYO 2004
- Country
- FULC United States
- MYO United States
- Employees
- FULC N/A
- MYO N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- MYO Industrial Specialties
- Sector
- FULC Health Care
- MYO Health Care
- Exchange
- FULC Nasdaq
- MYO Nasdaq
- Market Cap
- FULC 210.9M
- MYO 178.4M
- IPO Year
- FULC 2019
- MYO 2017
- Fundamental
- Price
- FULC $2.65
- MYO $4.64
- Analyst Decision
- FULC Hold
- MYO Strong Buy
- Analyst Count
- FULC 8
- MYO 4
- Target Price
- FULC $6.57
- MYO $9.75
- AVG Volume (30 Days)
- FULC 416.8K
- MYO 619.4K
- Earning Date
- FULC 05-12-2025
- MYO 03-10-2025
- Dividend Yield
- FULC N/A
- MYO N/A
- EPS Growth
- FULC N/A
- MYO N/A
- EPS
- FULC N/A
- MYO N/A
- Revenue
- FULC $80,000,000.00
- MYO $32,551,198.00
- Revenue This Year
- FULC N/A
- MYO $32.15
- Revenue Next Year
- FULC N/A
- MYO $17.59
- P/E Ratio
- FULC N/A
- MYO N/A
- Revenue Growth
- FULC 2752.05
- MYO 69.17
- 52 Week Low
- FULC $2.67
- MYO $2.51
- 52 Week High
- FULC $10.13
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- FULC 33.62
- MYO 40.53
- Support Level
- FULC $2.67
- MYO $4.57
- Resistance Level
- FULC $3.35
- MYO $5.04
- Average True Range (ATR)
- FULC 0.16
- MYO 0.24
- MACD
- FULC -0.01
- MYO -0.03
- Stochastic Oscillator
- FULC 5.93
- MYO 20.09
Stock Price Comparison Chart: FULC vs MYO
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).